Value of pancreatic duct stent placement combined with octreotide for reducing the postoperative pancreatic fistula rate in patients with diabetes undergoing pancreaticoduodenectomy

Table 1 Comparison of baseline data between the two groups of patients after propensity score matching, n (%)/mean ± SD

Index	Combined group (n = 60)	Control group (n = 60)	χ²/t	P value	SMD
					Before matching	After matching
Age (years)	62.5 ± 7.2	61.8 ± 7.5	0.512	0.610	0.359	0.095
Gender			0.138	0.710	0.312	0.067
male	35 (58.33)	33 (55.00)
female	25 (41.67)	27 (45.00)
BMI (kg/m²)	24.2 ± 2.8	23.9 ± 2.9	0.547	0.585	0.342	0.098
Duration of diabetes (year)	8.6 ± 4.2	8.2 ± 4.5	0.501	0.617	0.378	0.092
HbA1c (%)	7.5 ± 1.1	7.4 ± 1.2	0.429	0.669	0.589	0.087
Pancreatic texture			0.134	0.714	0.325	0.067
soft	27 (45.00)	29 (48.33)
hard	33 (55.00)	31 (51.67)
Main pancreatic duct diameter (mm)	2.8 ± 0.9	2.7 ± 0.8	0.608	0.544	0.321	0.095
Intraoperative blood loss (mL)	325.6 ± 112.3	332.4 ± 115.7	0.317	0.752	0.165	0.060
Operation time (minute)	318.5 ± 42.6	323.1 ± 45.2	0.571	0.569	0.231	0.098
Combined vascular resection			0.162	0.689	0.308	0.072
Yes	10 (16.67)	8 (13.33)
No	50 (83.33)	52 (86.67)
Pathological type			0.702	0.705	0.362	0.064
Pancreatic head carcinoma	29 (48.33)	27 (45.00)
Periampullary carcinoma	24 (40.00)	26 (43.33)
Benign pancreatic lesions	7 (11.67)	7 (11.67)
Anastomotic characteristics			0.156	0.693	0.324	0.061
Conventional suture group	30 (50.00)	28 (46.67)
Fine suture group	30 (50.00)	32 (53.33)

BMI: Body mass index.